Suchergebnisse - "Carlo-Stella, Carmelo"

PubPharm (258)

41

Risk of Cancer in Inflammatory Bowel Diseases : Umbrella Review and Reanalysis of Meta-analyses

enthalten in: Gastroenterology | 2022

von Piovani, D. | Hassan, C. | Repici, A. | +5

42

Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma : results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi

enthalten in: Annals of hematology | 2021

von Santoro, A. | Mazza, R. | Spina, M. | +24

43

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

enthalten in: Leukemia | 2021

von Merryman, R. | Castagna, L. | Giordano, L. | +63

44

Endothelial dysfunction and its critical role in COVID-19-associated coagulopathy : Defibrotide as an endothelium-protective, targeted therapy

enthalten in: EJHaem | 2021

von García-Bernal, D. | Richardson, E. | Vlodavsky, I. | +5

45

A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma

enthalten in: Investigational new drugs | 2021

von Balzarotti, M. | Magagnoli, M. | Canales, M. | +8

46

Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi

enthalten in: Annals of hematology | 2021

von Santoro, A. | Mazza, R. | Spina, M. | +24

47

Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi

enthalten in: Annals of hematology | 2021

von Santoro, A. | Mazza, R. | Spina, M. | +24

48

Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi

enthalten in: Annals of hematology | 2021

von Santoro, A. | Mazza, R. | Spina, M. | +24

49

Complete remission of follicular lymphoma after SARS-CoV-2 infection : from the "flare phenomenon" to the "abscopal effect"

enthalten in: European journal of nuclear medicine and molecular imaging | 2021

von Sollini, M. | Gelardi, F. | Carlo-Stella, C. | +1

50

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2) : a multicentre, open-label, single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2021

von Caimi, P. | Ai, W. | Alderuccio, J. | +15

CommentIn: Lancet Oncol. 2021 Jun;22(6):741-742. - PMID 33989556